Michael Gosselinis a pharmaceutical industry leader with more than 20 years of experience advancing drug development and manufacturing innovation. He serves as Vice President of Pharmaceutical Development at Aprecia Pharmaceuticals, where he leads formulation and product development efforts for the company’s proprietary 3D printing–based drug manufacturing platform. Dr. Gosselin brings deepexpertiseacross pharmaceutical development, technology-driven manufacturing, and cross-functional leadership, and he is recognized for translating complex scientific concepts into scalable, commercial solutions. Widely recognized for hisexpertisein pharmaceutical development and advanced manufacturing technologies, Dr. Gosselin is a frequent speaker at major industry conferences and has contributed to multiple scientific publications in the field. He holds degrees from The Ohio State University and is based in Cincinnati, Ohio.